US FDA Sending AZ, Other Cancer Sponsors Trial Design Message With Imfinzi AdComm

 
• By Sarah Karlin-Smith
  
red bullhorn with sign underneath that says "attention please"
The FDA's 25 July ODAC meeting appears important for many sponsors developing immunotherapies. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers